Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults – 2020 Update

CAN-eng

$0

free

CCCEP

< 30 min

Endocrinology

0.25 Credits

This course is expired! Browse All Courses
LEARN MORE

Course Description

This video helps pharmacists navigate the most recent clinical evidence published by Diabetes Canada for the pharmacologic glycemic management of type 2 diabetes in adults. The goal is to help pharmacists understand the evidence so they can confidently apply it in their practice and help counsel their patients effectively.

This program has received an unrestricted educational grant or in-kind support from Abbott, Janssen and Novo Nordisk.

Course Details

Expiry Date: 2022-10-22

Professions: Pharmacy

Faculty

Susie Jin, RPh, CDE, CRE

Michael Boivin, B.SC. Pharm, CDE, CTH

Rick Siemens, B.Sc. Pharm., B.Sc. Biol., CDE, CPT

Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM

James Kim, MBBCh, PgDip

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 0.25 CEUs.
CCCEP File Number: 1066-2021-3286-I-P

This program is developed in collaboration with Partners in Progressive Medical Education (PPME).

Learning Objective(s)

Upon completion of this continuing education program, participants will be better able to:

  • Review the key changes in the Diabetes Canada 2020 update of the Pharmacotherapy in Type 2 Diabetes chapter
  • Discuss optimal therapeutic regimens based on patient features, medication characteristics, clinical status, patient preferences and accessibility of treatment
  • Discuss how pharmacists can integrate these recommendations when managing people with type 2 diabetes in their practice
This course is expired! Browse All Courses